NEW YORK (AP) — During the early years of the COVID-19 pandemic, experts worried that disruptions to cancer diagnosis and treatment would cost lives. A new study suggests they were right. The federally funded study published Thursday by the medical journal JAMA Oncology is being called the first to assess the effects of pandemic-related disruptions on the short-term survival of cancer patients. Researchers found that people diagnosed with cancer in 2020 and 2021 had worse short-term survival

Tag-uri: Coronavirus